Ekachai Medical Care Public Company Limited(TH:EKH)
฿5.15+0.05 (+0.98%)
TH:EKH
Ekachai Medical Care Public Company Limited financials statements
฿5.15
At close:+0.05 (+0.98%)
Ekachai Medical Care Public Company Limited (EKH) Ratios
Ekachai Medical Care Public Company Limited Ratios
TH:EKH's free cash flow for Q2 2026 was ฿-22.96M. For the 2026 fiscal year, TH:EKH's free cash flow was decreased by ฿-87.29M and operating cash flow was ฿64.33M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.00 | 8.16 | 5.50 | 4.63 | 2.44 |
| Quick Ratio | 3.86 | 8.00 | 5.34 | 4.47 | 2.26 |
| Cash Ratio | 2.08 | 4.08 | 3.66 | 3.86 | 0.97 |
| Solvency Ratio | 0.86 | 1.14 | 1.16 | 1.99 | 1.84 |
| Operating Cash Flow Ratio | 1.14 | 1.32 | 1.73 | 1.63 | 2.03 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ฿ 802.37M | ฿ 1.59B | ฿ 822.87M | ฿ 616.22M | ฿ 218.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.03 | 0.03 | 0.01 | 0.01 | 0.03 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.01 | 0.01 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.24 | 1.18 | 1.17 | 1.18 | 1.23 |
| Debt Service Coverage Ratio | 212.76 | 199.12 | 235.85 | 389.52 | 231.24 |
| Interest Coverage Ratio | 176.50 | 172.24 | 220.97 | 162.26 | 235.44 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.10 | 0.10 | 0.03 | 0.04 | 0.05 |
| Net Debt to EBITDA | -1.30 | -1.98 | -1.63 | -0.98 | -0.29 |
| Profitability Margins | |||||
| Gross Profit Margin | 41.45% | 45.00% | 44.63% | 41.92% | 47.42% |
| EBIT Margin | 27.39% | 27.20% | 30.98% | 65.56% | 37.21% |
| EBITDA Margin | 34.23% | 33.97% | 38.08% | 72.87% | 43.78% |
| Operating Profit Margin | 23.95% | 25.20% | 30.21% | 25.00% | 37.09% |
| Pretax Profit Margin | 27.25% | 27.05% | 30.85% | 65.40% | 37.05% |
| Net Profit Margin | 21.16% | 21.43% | 24.60% | 52.58% | 30.08% |
| Continuous Operations Profit Margin | 21.90% | 22.31% | 25.01% | 52.54% | 29.70% |
| Net Income Per EBT | 77.64% | 79.22% | 79.74% | 80.40% | 81.18% |
| EBT Per EBIT | 113.78% | 107.36% | 102.11% | 261.65% | 99.90% |
| Return on Assets (ROA) | 8.91% | 8.86% | 12.09% | 24.52% | 25.88% |
| Return on Equity (ROE) | 11.06% | 10.47% | 14.15% | 28.85% | 31.91% |
| Return on Capital Employed (ROCE) | 11.24% | 11.25% | 16.23% | 12.80% | 37.02% |
| Return on Invested Capital (ROIC) | 9.01% | 9.22% | 13.12% | 10.25% | 29.51% |
| Return on Tangible Assets | 8.93% | 8.89% | 12.10% | 24.55% | 25.93% |
| Earnings Yield | 6.48% | 5.75% | 5.90% | 10.32% | 8.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.57 | 14.20 | 11.38 | 10.39 | 9.54 |
| Payables Turnover | 18.78 | 15.71 | 19.39 | 21.86 | 30.83 |
| Inventory Turnover | 18.17 | 19.71 | 20.16 | 19.01 | 18.69 |
| Fixed Asset Turnover | 0.95 | 1.40 | 1.80 | 1.55 | 1.74 |
| Asset Turnover | 0.42 | 0.41 | 0.49 | 0.47 | 0.86 |
| Working Capital Turnover Ratio | 0.96 | 1.00 | 1.44 | 2.11 | 5.39 |
| Cash Conversion Cycle | 35.20 | 20.97 | 31.36 | 37.65 | 45.95 |
| Days of Sales Outstanding | 34.55 | 25.70 | 32.07 | 35.15 | 38.25 |
| Days of Inventory Outstanding | 20.09 | 18.52 | 18.11 | 19.20 | 19.53 |
| Days of Payables Outstanding | 19.44 | 23.24 | 18.82 | 16.70 | 11.84 |
| Operating Cycle | 54.64 | 44.21 | 50.18 | 54.35 | 57.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.42 | 0.40 | 0.52 | 0.50 | 0.58 |
| Free Cash Flow Per Share | -0.06 | 0.08 | 0.40 | 0.36 | 0.45 |
| Dividend Paid and CapEx Coverage Ratio | 0.56 | 0.46 | 1.21 | 1.91 | 1.69 |
| Capital Expenditure Coverage Ratio | 0.88 | 1.25 | 4.37 | 3.51 | 4.47 |
| Operating Cash Flow Coverage Ratio | 4.45 | 4.04 | 22.41 | 13.78 | 12.33 |
| Operating Cash Flow to Sales Ratio | 0.28 | 0.24 | 0.30 | 0.31 | 0.32 |
| Free Cash Flow Yield | -1.16% | 1.26% | 5.56% | 4.40% | 6.79% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.50 | 17.16 | 16.79 | 9.63 | 12.37 |
| Price-to-Sales (P/S) Ratio | 3.27 | 3.73 | 4.17 | 5.09 | 3.71 |
| Price-to-Book (P/B) Ratio | 1.71 | 1.82 | 2.40 | 2.80 | 3.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -86.35 | 79.19 | 17.98 | 22.75 | 14.74 |
| Price-to-Operating Cash Flow Ratio | 11.78 | 15.70 | 13.86 | 16.27 | 11.44 |
| Price-to-Earnings Growth (PEG) Ratio | -1.15 | -1.23 | -0.34 | 0.17 | 0.03 |
| Enterprise Value Multiple | 8.24 | 8.99 | 9.30 | 6.01 | 8.18 |
| Enterprise Value | 3.50B | 3.99B | 4.28B | 4.59B | 4.11B |
| EV to EBITDA | 8.24 | 8.99 | 9.30 | 6.01 | 8.18 |
| EV to Sales | 2.82 | 3.05 | 3.54 | 4.38 | 3.58 |
| EV to Free Cash Flow | -74.59 | 64.89 | 15.29 | 19.55 | 14.22 |
| EV to Operating Cash Flow | 10.18 | 12.87 | 11.79 | 13.98 | 11.05 |
| Tangible Book Value Per Share | 3.10 | 3.69 | 3.05 | 2.92 | 1.73 |
| Shareholders’ Equity Per Share | 2.91 | 3.49 | 3.01 | 2.89 | 1.70 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.18 | 0.19 | 0.20 | 0.20 |
| Revenue Per Share | 1.52 | 1.70 | 1.73 | 1.59 | 1.80 |
| Net Income Per Share | 0.32 | 0.37 | 0.43 | 0.84 | 0.54 |
| Tax Burden | 0.78 | 0.79 | 0.80 | 0.80 | 0.81 |
| Interest Burden | 1.00 | 0.99 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.18 | 0.22 | 0.19 | 0.19 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.31 | 0.88 | 1.22 | 0.48 | 0.88 |
Currency in THB
